Drugs / Yasmin 20
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00624130 | Mar 2004 → Jun 2005 | — | Bayer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Yasmin 20 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00624130 ↗ |
| Route | Oral | “Tablet p.o. (oral)” NCT00624130 ↗ |